Sensitization by 5-azacytidine toward death receptor-induced hepatic apoptosis

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 1, 2009, Pages 107-115

  Weiland, Timo ^a   Weiller, Markus ^a   Kunstle, Gerald ^a   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; 5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 7; CASPASE INHIBITOR; CYCLOHEXIMIDE; DACTINOMYCIN; DEATH RECEPTOR; DNA METHYLTRANSFERASE INHIBITOR; FAS LIGAND; N,4 TOSYLLYSYL CHLOROMETHYL KETONE; PROTEIN BAX; PROTEIN P53; RG 108; S ADENOSYLHOMOCYSTEINE; SERINE PROTEINASE INHIBITOR; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; CASPASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN HEPG2; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; LIVER TOXICITY; MEMBRANE DAMAGE; NONHUMAN; PHARMACODYNAMICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL DEATH; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FLUORESCENCE MICROSCOPY; LIVER; LIVER CELL; LIVER TUMOR; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; AZACITIDINE; CASPASES; CELL CULTURE TECHNIQUES; CELL DEATH; CELL SURVIVAL; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MICE; MICROSCOPY, FLUORESCENCE; RECEPTORS, DEATH DOMAIN;

EID: 59149089041     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.143560     Document Type: Article

References (38)

1. Beg AA and Baltimore D (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782-784.
2. Bouchier-Hayes L, Lartigue L, and Newmeyer DD (2005) Mitochondria: pharmacological manipulation of cell death. J Clin Invest 115:2640-2647.
3. Broker LE, Kruyt FA, and Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11:3155-3162.
4. Brown JM and Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5:231-237.
5. Brown JM and Wilson G (2003) Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us? Cancer Biol Ther 2:477-490.
6. Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, and Pantazis P (2001) Induction of apoptosis in 9-nitrocamptothecin- treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short). Cancer Res 61:7148-7154.
7. Chipuk JE, Maurer U, Green DR, and Schuler M (2003) Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4:371-381.
8. Cihak A (1974) Biological effects of 5-azacytidine in eukaryotes. Oncology 30:405-422.
9. Cole PD, Zebala JA, and Kamen BA (2005) Antimetabolites: a new perspective. Drug Discov Today 2:337-342.
10. Danial NN and Korsmeyer SJ (2004) Cell death: critical control points. Cell 116: 205-219.
11. Dünstl G, Weiland T, Schlaeger C, Nüssler A, Kunstle G, and Wendel A (2007) Activation of an alternative death receptor-induced signaling pathway in human hepatocytes under caspase arrest. Arch Biochem Biophys 462:140-149.
12. Egger L, Schneider J, Rhême C, Tapernoux M, Häcki J, and Borner C (2003) Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Differ 10:1188-1203.
13. Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, et al. (2005) Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. Cancer Res 65:11469-11477.
14. Friesen C, Herr I, Krammer PH, and Debatin KM (1996) Involvement ofthe CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574-577.
15. Fulda S and Debatin KM (2006a) 5-Aza-2′-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 25:5125-5133.
16. Fulda S and Debatin KM (2006b) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811.
17. Guan B, Yue P, and Clayman GL, Sun SY (2001) Evidence that death receptor DR4 is a DNA damage-inducible, p53-regulated gene. J Cell Physiol 188: 98-105.
18. Hrodek O and Vesely J (1971) 5-Azacytidine in childhood leukaemia. Neoplasma 18:493-503.
19. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Academic Press, Washington, DC.
20. Johnson DE (2000) Noncaspase proteases in apoptosis. Leukemia 14:1695-1703.
21. Kaminskas E, Farrell AT, Wang YC, Sridhara R, and Pazdur R (2005) FDA drug approval summary: azacytidine (5-azacytidine, Vidaza) for injectable suspension. Oncologist 10:176-182.
22. Kerr JF, Wyllie AH, and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239 -257.
23. Kidd VJ, Lahti JM, and Teitz T (2000) Proteolytic regulation ofapoptosis. Semin Cell Dev Biol 11:191-201.
24. Kunstle G, Leist M, Uhlig S, Revesz L, Feifel R, MacKenzie A, and Wendel A (1997) ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 55:5-10.
25. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, and Wendel A (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcrip-tional arrest. J Immunol 153:1778-1788.
26. Leist M and Jäättelä M (2001) Triggering of apoptosis by cathepsins. Cell Death Differ 8:324-326.
27. Liu N, Wang Y, and Ashton-Rickardt PG (2004) Serine protease inhibitor 2Ainhibits caspase-independent cell death. FEBS Lett 569:49-53.
28. MicheauOand TschoppJ(2003) Induction ofTNFreceptorI-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190.
29. Momparler RL, Samson J, Momparler LF, and Rivard GE (1984) Cell cycle effects and cellular pharmacology of 5-aza-2′-deoxycytidine. Cancer Chemother Pharmacol 13:191-194.
30. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, and Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95(APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403-413.
31. O'Connell AR and Stenson-Cox C (2007) A more serine way to die: defining the characteristics of serine protease-mediated cell death cascades. Biochim Biophys Acta 1773:1491-1499.
32. Philchenkov A, Zavelevich M, Kroczak TJ, and Los M (2004) Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 26:82-97.
33. Santini V, Kantarjian HM, and Issa JP (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134: 573-586.
34. Schimmer AD, Hedley DW, Penn LZ, and Minden MD (2001) Receptor- and mito-chondrial mediated apoptosis in acute leukemia: a translational view. Blood 98: 3541-3553.
35. Takimoto R and El-Deiry WS (2001) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19:1735-1743.
36. Thorburn J, Bender LM, Morgan MJ, and Thorburn A (2003) Caspase- and serine protease dependent apoptosis by the death domain of FADD in normal epithelial cells. Mol Biol Cell 14:67-77.
37. Winkley MWand Robins RK (1970) Direct glycosylation of1,3,5-triazinones. A new approach to the synthesis of the nucleoside antibiotic 5-azacytidine (4-amino-1- beta-D-ribofuranosyl-1,3,5-triazin-2-one) and related derivatives. J Org Chem 35: 491-495.
38. Yoo CB and Jones PA (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5:37-50.